RecruitingNot Applicable

Evaluation of the Efficacy of an Innovative Digital Therapeutic Medical Device, Lyv Endo, for the Management of Patients With Endometriosis

France410 participantsStarted 2025-07-21

Plain-language summary

The main objective of this clinical study is to evaluate the clinical impact of using an innovative digital therapeutic device on the quality of life of patients with endometriosis. The working hypothesis is that the therapeutic digital medical device Lyv Endo may improve quality of life and reduce symptom intensity by enhancing patient engagement in the management of their condition. This justifies the need to evaluate the effect of Lyv Endo as a complement to standard medical care.

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women ≥18 years old * with confirmed endometriosis diagnosis * symptomatic patients (NRS ≥ 4 on one or more symptoms) * French-speaking * Owning a smartphone with internet/data, * covered by French social security Exclusion Criteria: * Planned surgery during the study or surgery in the past 8 weeks * Fertility hormone treatment during study * Previous use of full Lyv Endo app or pilot program * Pregnant or breastfeeding * Under legal protection (guardianship, etc.) * Cognitive or psychiatric conditions compromising consent * Judged non-autonomous by investigator * Participation in another interventional study

What they're measuring

Clinical impact

Timeframe: Baseline and 3 months

Trial details

NCT IDNCT07175857

SponsorLyv Healthcare

Sponsor typeINDUSTRY

Study typeINTERVENTIONAL

Primary completion2026-08-31

View on ClinicalTrials.gov More Endometriosis trials